APGE
Apogee Therapeutics, Inc.
135.10$
+0.0%
vs. previous close
Closing price · As of: Sep 3, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Apogee Therapeutics, Inc. (APGE) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 09/03/2026 | Current report (8-K) | Apogee Therapeutics, Inc. (APGE): Termination of a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; Material Modifications to Rights of Security Holders; Changes in Control of Registrant; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Amendments to Articles of Inco | View report ↗ |
| 08/11/2026 | Current report (8-K) | Apogee Therapeutics, Inc. (APGE): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Submission of Matters to a Vote of Security Holders | View report ↗ |
| 08/10/2026 | Current report (8-K) | Apogee Therapeutics, Inc. (APGE): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: September 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.